Afficher la notice abrégée

dc.contributor.authorSeca, Ana M. L*
dc.contributor.authorPinto, Diana Cláudia*
dc.date.accessioned2021-02-11T09:09:14Z
dc.date.available2021-02-11T09:09:14Z
dc.date.issued2019*
dc.date.submitted2019-08-28 11:21:27*
dc.identifier35928*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/42231
dc.description.abstractMany macro and micro species, from terrestrial and aquatic environments, produce structurally unique compounds and, in many countries, still are the primary sources of medicines. In fact, secondary metabolites are an important source of chemotherapeutic agents but are also lead compounds for synthetic modification and the optimization of biological activity. Therefore, the exploitation of secondary metabolites, or their inspired synthetic compounds, offers excellent opportunities for the pharmaceutical industry. This Medicines Special Issue focuses on the great potential of secondary metabolites for therapeutic application. The Special Issue contains 16 articles reporting relevant experimental results, and an overview of bioactive secondary metabolites, their biological effects, and new methodologies that improve and accelerate the process of obtained lead compounds with regard to new drug development. We would like to thank all 83 authors, from all over the world, for their valuable contributions to this Special Issue.*
dc.languageEnglish*
dc.subjectQD1-999*
dc.subjectQ1-390*
dc.subject.classificationthema EDItEUR::P Mathematics and Science::PN Chemistryen_US
dc.subject.otherantitumor*
dc.subject.othertriterpenoids*
dc.subject.otherseaweeds*
dc.subject.otherditerpenes*
dc.subject.otherBoswellia*
dc.subject.otherantioxidant activity*
dc.subject.otherantiplasmodial*
dc.subject.otherMaytenus chiapensis*
dc.subject.otherphenolic derivatives*
dc.subject.othersecondary metabolites*
dc.subject.othermedicinal applications*
dc.subject.otherMalus x domestica*
dc.subject.otherpectin*
dc.subject.othercytotoxic activity*
dc.subject.otherxanthine oxidase*
dc.subject.otherphytochemistry*
dc.subject.otherantioxidant*
dc.subject.otherScabiosa*
dc.subject.othersugars*
dc.subject.othersargaquinoic acid*
dc.subject.otherpentacyclic triterpenoids*
dc.subject.otheranalysis*
dc.subject.otherantimicrobial and anticancer activity*
dc.subject.otheriridoids*
dc.subject.otherTuscany*
dc.subject.otherGC-MS*
dc.subject.other(-)-rabdosiin*
dc.subject.otherkratom*
dc.subject.otherplant defense*
dc.subject.othercembranoids*
dc.subject.othertingenone*
dc.subject.otherdeoxypodophyllotoxin*
dc.subject.otheranticancer*
dc.subject.otherpristimerin*
dc.subject.otherinflammation*
dc.subject.otherboswellic acids*
dc.subject.otherplants*
dc.subject.otheranti-inflammatory*
dc.subject.otherlegalization*
dc.subject.otherMitragyna speciosa*
dc.subject.otherOcimum sanctum*
dc.subject.othercordycepin*
dc.subject.othercytotoxic*
dc.subject.othermedicine*
dc.subject.otherArtemisia species*
dc.subject.otherantimicrobial activity*
dc.subject.otherlignans*
dc.subject.otherArtemisia vachanica*
dc.subject.otherCordyceps militaris*
dc.subject.otherfrankincense*
dc.subject.otherancient varieties*
dc.subject.othersargahydroquinoic acid*
dc.subject.otherTajikistan*
dc.subject.otherantiSMASH*
dc.subject.otherABTS*
dc.subject.otherpolyphenols*
dc.subject.othertherapeutics*
dc.subject.otherinfectious diseases*
dc.subject.otherantibacterial*
dc.subject.othernutraceutics*
dc.subject.othertotal phenolics*
dc.subject.otherLC-MS/MS*
dc.subject.otherinnate immunity*
dc.subject.otherHPLC-PAD*
dc.subject.othersarganaphthoquinoic acid*
dc.subject.otherbiosynthetic gene clusters*
dc.subject.otherDPPH*
dc.subject.otherEGCG*
dc.subject.othercneorubenoids*
dc.subject.otherPPAR-?*
dc.subject.otherbowel diseases*
dc.subject.otheramentoflavone*
dc.subject.othermolecular docking*
dc.subject.othersargachromenoic acid*
dc.subject.othercannabinoids*
dc.subject.otherflavonoids*
dc.subject.otheressential oils*
dc.subject.otherTCM*
dc.subject.otherHPLC-PDA*
dc.subject.otherascorbic acid*
dc.subject.otherantioxidants*
dc.subject.otherLamiaceae*
dc.subject.othernanoemulsion*
dc.subject.othermalaria*
dc.subject.othertherapeutic uses*
dc.subject.otherquinonemethide triterpenoids*
dc.subject.otherartemisinin*
dc.subject.othernatural products*
dc.subject.otherbiological activities*
dc.subject.otherFRAP*
dc.subject.othertoxicology*
dc.subject.otherdefensins*
dc.subject.otherCelastraceae*
dc.subject.othercannabis*
dc.subject.othervector control*
dc.subject.otherJuniperus*
dc.subject.otheranalytical determination*
dc.titleBiological Potential and Medical Use of Secondary Metabolites*
dc.typebook
oapen.identifier.doi10.3390/books978-3-03921-188-3*
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0*
oapen.relation.isbn9783039211883*
oapen.relation.isbn9783039211876*
oapen.pages284*
oapen.edition1st*


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by-nc-nd/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by-nc-nd/4.0/